Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 12;17(12):e0278883. doi: 10.1371/journal.pone.0278883

Analysis of the clinical and radiological outcomes of percutaneous cervical nucleoplasty: A case–control study

Chien-Hua Chen 1, You-Pen Chiu 2,3, Hui-Ru Ji 2,3, Chin-Ying Wu 4,5, Jeng-Hung Guo 3,6,7, Fu-Shan Jaw 1, Cheng-Di Chiu 2,3,6,7,8,*
Editor: Andrea Giannini9
PMCID: PMC9744319  PMID: 36508407

Abstract

Background

Percutaneous cervical nucleoplasty (PCN) is a simple, safe, and effective treatment for contained cervical herniated intervertebral disc (CHIVD). However, few studies have compared the actual benefits of PCN against conservative treatment (CT), either clinically or radiographically.

Purpose

The present study sought to analyze and to compare the outcomes of symptomatic contained CHIVD treated with PCN or CT.

Methods

The present study was designed as a case–control comparative study. Patients who indicated for PCN after a failed CT for more than 6 months were recruited. After the exclusion of some patients who did not meet the selection criteria of the study, we finally enrolled 71 patients treated with PCN. In addition, another 21 patients who indicated for PCN but finally chose to receive CT continuously were also enrolled and categorized as the control group. All patients completed the 6-month follow-up. Pain levels and functional outcomes were evaluated pre- and post-operatively by assessing the visual analog scale (VAS), Oswestry Disability Index (ODI), and Neck Disability Index (NDI). Radiographic images of 72 of 104 intervened segments were collected to measure disc height and other cervical spinal alignments, such as range of motion, C2–7 Cobb’s angle, and C2–7 sagittal vertical axis.

Results

Compared with the CT group, the PCN group showed significantly better outcomes on VAS, ODI, and NDI at the 1-month post-operative follow-up, which continued through at least the 6-month follow-up (P < 0.01 for VAS and P < 0.05 for ODI and NDI). The mean disc height significantly decreased, from 6.04 ± 0.85 mm to 5.76 ± 1.02 mm, 3 months after PCN treatment (P = 0.003). However, the degree of disc height decrease did not correlate with the changes of the substantial VAS improvement.

Conclusions

To provide therapeutic benefits for symptomatic contained CHIVD patients after an invalid CT for 6 months, PCN seems to be a better option than CT. The reduced disc heights did not alter the clinical outcomes of PCN.

Introduction

Cervical disc disorders represent a major cause of daily life difficulties among adults. On average, 1 in every 1,000 people suffers from cervical disc-related pain, which is associated with high medical expenses [1]. Cervical discogenic pain is often caused by a cervical herniated intervertebral disc (CHIVD). The size and location of the herniated disc and the associated compression imposed on adjacent nervous system structures can cause many symptoms, including pain, soreness, and numbness in the neck, shoulders, and arms [2]. Most patients with symptomatic CHIVD initially receive conservative treatment (CT), such as medication, rehabilitation, and cervical traction. Based on predictive factors of CT, if no subjective or objective improvement is observed within 6 months after CT treatment or the disease is aggravated, surgical treatment may need to be considered [3].

Anterior cervical decompression and fusion (ACDF) or artificial disc replacement (ADR), which both aim to decompress the cervical spinal cord and nerve roots, remain the gold standards of surgical treatment for CHIVD. However, these treatments are also associated with the risk of damage to nearby tissues (for example, the esophagus, recurrent laryngeal nerves, and thyroid arteries) or adjacent disc levels [4, 5]. Percutaneous cervical nucleoplasty (PCN) is a method for percutaneous disc decompression that was first permitted by the U.S. Food and Drug Administration in 1999 to treat symptomatic contained discs [6]. PCN combines nucleus pulposus ablation with thermal coagulation and has, thus, been referred to as a coblation technique [7]. PCN is effective due to the physical reduction of intradiscal pressure; a small reduction in contained disc volume results in a large fall in intradiscal pressure [8]. In addition, thermal PCN coblation therapy can further decrease pain from the chemical reduction of local inflammatory factors such as phospholipase A2 and interleukin-1 and the induction of regenerative cytokines such as interleukin-8 [911]. This technique is easy to perform and can effectively reduce the compression of intervertebral discs, minimizing the impacts on surrounding healthy tissues [12]. Many studies have reported PCN to be a safe and effective surgery over the long term [7, 13, 14]. Although other percutaneous techniques, such as percutaneous cervical discectomy (PCD), have been adopted by some physicians, the clinical results of PCN have not been reported to be inferior to those of PCD in several comparative studies [13, 15, 16]. To our knowledge, there is a limited number of studies that have evaluated the real benefits gained from PCN compared with CT, especially among these patients who are already indicated for surgery [17]. Although a few studies have reported serial imaging changes after PCN, these studies have not provided and examined the factors affecting clinical outcomes [18].

To date, the role played by PCN has remained debatable, and a comparative case-control study may be necessary to determine the benefits of PCN relative to other therapeutic methods [11]. Thus, the aim of the study was to evaluate the clinical outcomes and imaging parameters in patients treated with PCN or CT to provide a better understanding of the therapeutic effects of PCN in patients suffering from symptomatic contained CHIVD.

Materials and methods

Patient enrollment and selection

The protocol of the present study received approval from the research committee of China Medical University Hospital (CMUH110-REC2-113, S1 Appendix). All methods were performed in accordance with relevant regulations. We collect data from patients who met the selection criteria for receiving PCN at a single medical center. The surgeries were performed by the same neurosurgeon. The inclusion criteria were as follows: (1) aged 20–60 years; (2) diagnosed with contained CHIVD demonstrated by magnetic resonance imaging (MRI); (3) persistent neck pain more than radicular pain without signs of improvement after six months of conservative treatment (physical therapy or medication); and (4) a limited degree of disc degeneration (>50% of disc height relative to adjacent disc). (5) Neither sensory nor motor neurologic deficit existed. Subsequently, some cases were excluded due to a history of other surgical treatment in the neck, too many painful discs (>3 segments), a combined surgery with PCN, or the patient’s refusal to participate. Eventually, we collected 71 cases with complete data for the 6-month follow-up period. Twenty-one patients who met the same selection criteria but finally chose to receive CT continuously were categorized as the control group. The participants were enrolled in each group at the physician’s discretion and not specifically for this study’s purpose. All patients provided written informed consent and were provided with a comprehensive explanation of the study content. In order to protect the subject’s privacy, the alternative serial number will be used for de-identification to improve the protection of subject’s privacy and data security.

The technique of PCN

The patient was placed in a supine position under local anesthesia with his or her neck mildly extended. With the aid of three-dimensional C-arm image and the experienced hands of the surgeon, a 17-gauge Crawford spinal needle was advanced through the avascular space between the right carotid sheath and esophagus, pointing to the nucleus pulpous of the targeted disc, and the final locations were confirmed by provocation discography with 0.2 c.c. contrast media injected into the index disc space. Then, the coblation instrument (ArthroCare®; ArthroCare Cooperation, Sunnyvale, CA) with a 1-mm diameter was used to produce radiofrequency energy in low-temperature plasma (typically 40–70°C) to remove a section of the compressed nucleus pulpous tissue. Three circular coblations were performed at the 1/4, 2/4 and 3/4 locations within the full length of the disc space.

Pain and functional indexes

All enrolled patients first visited an outpatient clinic, where they were asked to indicate their pain level using a 10-cm visual analog scale (VAS) [19]. With the assistance of a clinical study nurse, they also completed the Oswestry Disability Index (ODI) and the Neck Disability Index (NDI), which measure both disability and quality of life [20, 21]. The outcome records at the time the study subjects were categorized as either PCN or CT group prior to treatment were defined as baseline. All questionnaires were conducted at baseline, and 1, 3, and 6 months after treatments. Some surveys were completed using telephone interviews due to traveling difficulties. To evaluate the efficacy of PCN in or study subjects, the primary outcomes of the study were the questionnaire results of VAS, ODI, and NDI. The secondary outcomes were the changes of radiographic parameters after PCN.

Radiographic parameters

MRI and X-ray imaging at baseline and 3-month follow-up were obtained to calculate the image parameters, which represent the biomechanical status of the treated spinal segments [22]. For single-level examinations, disc height and range of motion (ROM) were measured using a sagittal or flexion/extension X-ray images, respectively. The C2–7 sagittal vertical axis (SVA), which represents the distance between the plumb line from the center of the C2 to the upper-posterior edge of the C7, indicated the balance of the sagittal plane. The curvature of the cervical spine was represented by the Cobb’s angle for C2–7 or the angle between the superior and inferior endplate that were employed to evaluate the cervical spinal lordosis. Both the SVA and Cobb’s angle were measured according to the X-ray images. All the measurements were performed by a radiologist or neurosurgeon using RadiAnt DICOM Viewer (Medixant, Poland).

Statistics

A two-tailed Student’s t-test was employed to analyze differences in demographic data and image parameters across groups. The analyses of VAS, ODI, and NDI were performed using two-way analysis of variance, with between-group analyses performed using Sidak’s multiple comparisons test. All results with a P-value less than 0.05 were deemed significant. Statistical analyses were performed using GraphPad Prism 7 (GraphPad Software, Inc., CA, US).

Results

We enrolled 71 PCN cases and 21 CT cases who completed the 6-month follow-up assessments, including outcome evaluations and image acquisition (Fig 1). For the PCN group, the re-surgery rate for the same or adjacent discs was approximately 4.44% (4/90), with surgery occurring within a mean of 30.44 ± 24.36 months, including three patients who received additional PCN and one microdiscectomy with ADR. The demographic characteristics of both groups are shown in Table 1. The average ages were 46.18 ± 8.01 years for the PCN group and 45.34 ± 7.84 years for the CT group, and most cases were younger than 55 years, indicating a majority of younger age brackets for the study cohort. A slightly lower body mass index (BMI) was observed in the PCN group (P = 0.034). However, no significant differences were identified for age, baseline VAS, ODI, or NDI values between groups. After treatment, pain and functional outcome assessments (Fig 2) revealed significant improvements in the VAS, ODI, and NDI values for the PCN group from 1 to 6 months compared to that at baseline (P < 0.01 for VAS, ODI, and NDI). At 3-month follow up, in the CT group, further recoveries were also detected (P < 0.05 at 3 m and 6 m for VAS and at 6 m for ODI and NDI). Moreover, at the 6-month follow-up period used to assess therapeutic effects, PCN treatment was significantly superior to CT for both pain relief and functional improvements (P < 0.01 for VAS, P < 0.05 for ODI at 1 m, and for NDI at 1m and 3m). In addition, improvements in pain were not associated with demographic factors, such as age and BMI (Fig 3). Table 2 shows the estimated parameters measured from the images obtained at baseline for the CT group and the pre- and post-operative periods for the PCN group, which represent the biomechanical status of the cervical spine after treatment. Of 93 measured discs treated with PCN, a significant reduction in disc height (6.04 ± 0.85 mm vs. 5.76 ± 1.02 mm) was noted as early as 3 months (P < 0.01). However, no correlation was observed between the loss of disc height and substantial VAS improvements (Fig 3). No significant within-group or between-group differences were found on the C2–7 Cobb’s angle, C2–7 SVA, or ROM after treatment. These results implied that the loss of disc content was the only radiographic change observed, and neck mobility and curvature were not affected by PCN.

Fig 1. A flow diagram showing patient enrollment and the eligibility criteria applied to the study.

Fig 1

PCN: percutaneous cervical nucleoplasty; CT: conservative treatment.

Table 1. Demographic data.

Study group CT (n = 21) a PCN (n = 71) P-value
Age (y) 43.67 ± 9.88 46.18 ± 8.01 .234
> 55 3 10
≤ 55 18 61
Sex (F/M) 9/12 34/38
BMI (kg/m2) 26.81 ± 4.19 24.23 ± 3.89 .034
Levels treated (l level/2 levels/3 levels) b 10/8/3 22/42/7
Total disc spaces (segments) 35 127
C3–4 6 14
C4–5 7 31
C5–6 13 57
C6–7 9 25
Baseline VAS (score) 6.05 ± 1.29 6.51 ± 1.75 .262
Baseline ODI (%) 34.67 ± 15.33 35.97 ± 20.63 .790
Baseline NDI (%) 37.05 ± 14.77 41.20 ± 18.32 .345

a Data is presented as the mean ± SD.

b The level treated indicates the total counts of cervical spinal segments in patients.

BMI: body mass index.

VAS: visual analog scale.

ODI: Oswestry Disability Index.

NDI: Neck Disability Index.

Fig 2. Six-month follow-up of pain scales and disability indexes.

Fig 2

A chart showing the estimated VAS (A), ODI (B), and NDI (C) from the baseline record compared with those for the 6-month follow-up. *, **, and *** indicate between-group significance differences, with P-values < 0.05, < 0.01, and < 0.001, respectively. $ represents P < 0.01 compared with baseline value for the PCN group. # represents P < 0.05 compared with baseline value for the CT group. All data are presented as the mean ± SD. VAS: visual analog scale; ODI: Oswestry Disability Index; NDI: Neck Disability Index.

Fig 3. Correlation analyses between substantial pain relief and prognostic factors.

Fig 3

The relationships between visual analog scale (VAS) improvement and age (A), body mass index (BMI) (B), baseline disc height (C), and disc height changes (D) at the 3-month follow-up were modeled by linear regression.

Table 2. Estimated image parameters.

Image evaluations Study group Follow-up time (n) a Statistics b
Mean ± SD P-value
Disc height (mm) CT baseline (31) 6.11 ± 1.19 .217
PCN baseline (93) 6.04 ± 0.85 .003
3 m (93) 5.76 ± 1.02
Cobb’s angle (degrees) CT baseline (18) 10.72 ± 4.82 .808
PCN baseline (40) 10.13 ± 6.61 .413
3 m (40) 11.41 ± 8.10
SVA (mm) CT baseline (18) −12.62 ± 6.75 .179
PCN baseline (40) −9.96 ± 6.95 .327
3 m (40) −11.75 ± 10.17
ROM (degrees) CT baseline (22) 4.69 ± 3.58 .123
PCN baseline (57) 6.38 ± 4.58 .717
3 m (57) 6.62 ± 4.34

Sagittal X-ray images was used to measure disc height, Cobb’s angle, and sagittal vertical axis (SVA). Extensional and flexional X-ray images were used to measure the range of motion (ROM). All post-operative measurements were obtained from the newest follow-up images after 3 months.

a Some treated discs were excluded due to blurry X-ray images, incomplete image collection, or images from outside facilities. The n values for disc height and ROM represent the number of evaluated disc, whereas the n values for Cobb’s angle and SVA represent total cases.

b Statistical analyses of between-group differences were performed using Student’s t-test.

CT: conservative treatment.

PCN: percutaneous cervical nucleoplasty.

SVA: sagittal vertical axis.

ROM: range of motion.

Discussion

Many reports, including retrospective, prospective, meta-analyses and randomized controlled studies, have indicated that PCN is a long-term safe and effective modality for treating contained CHIVD [7, 16, 17, 23]. The effectiveness of PCN has been reported as not inferior to anterior cervical discectomy (ACD) or PCD [13, 15, 16]. Furthermore, a randomized controlled trial by Rooij et al. also suggested that for single-level contained CHIVD, long-term effectiveness is not significantly different between ACD and PCN, and concluded that PCN can be a good alternative to ACD [24]. However, Epstein et al. reported that CT could achieve similar improvements as PCN [25]. Our study found that the PCN group had significantly superior outcomes compared with the CT. group, including earlier recovery from pain and functional limitations for as long as 6 months (Fig 2). Unlike lumbar HIVD, less spontaneous regression was identified with CHIVD, reducing the effectiveness of CT for cervical discogenic pain [26, 27]. Our results also indicated that the extension of the CT period for more than 6 months can only gain limited effects and is less efficient than receiving PCN for patients suffering from symptomatic contained CHIVD. These findings suggested that early PCN intervention after 6 months’ invalid CT should be considered to achieve prompt and long-term satisfactory results. On the other hand, with regard to safety, only some rare complications, such as inferior thyroid artery injury or spondylodiskitis, have been described [28, 29].

Cervical disc degeneration and reduced disc height are potential risk factors for the prediction of neck pain in patients [30]. However, some studies have reported that larger or optimal interbody implants do not achieve better clinical outcomes in the case of increased disc height [31, 32]. In addition, the acceleration of disc degeneration has been reported as a potential drawback of PCN [18, 33]. The present study attempted to identify temporal evidence of imaging changes after PCN. We noted a significant decrease in cervical disc height among PCN patients that could be detected as early as 3 months after surgery (Table 2). But no correlation was detected between changes in disc height and PCN outcomes (Fig 3), indicating that decreased disc height after PCN cannot be used as an indicator of poor outcome. At our center, we performed the standard three-point circular coblation technique for PCN (at 1/4, 2/4, and 3/4) in each cervical disc space (Fig 4) [34]. We propose that some amount of decrease in disc height following PCN may represent an acceptable trade-off for apparent symptom improvements. However, whether the use of fewer circular coblation points would reduce the decrease in disk height or provide similar efficacy for pain relief and functional improvements remain unknown. Further large-scale studies and longer follow-up periods remain necessary to determine whether the observed decrease in disc height will result in symptom progression, which may contribute to the eventual necessity of ACDF or ADR. In our series, all patients who received PCN tolerated the whole course well, and no complications were reported. The imaging parameters, such as ROM, Cobb’s angle, and the SVA, did not change, indicating that the PCN-induced decrease in disc height did not alter the sagittal or axial balance of the patients.

Fig 4. Radiographic and magnetic resonance images from a sample patient.

Fig 4

(A) Representative intraoperative images showing the three-point circular coblation technique of PCN. The white arrows and dotted lines indicate the sequence and the target locations for the coblations performed in the target disc. Pre- and post- operative images of sagittal (B) and axial (C) T2-weighted MRI from a 48-year-old patient with C5-6 disc protrusion. The white arrows/circle indicate the improvement of the entrapped left C5/6 nerve root due to CHIVD.

Klessinger reported data for 133 PCN patients, which showed a 19.5% re-surgery rate; 57.7% of the reoperations were performed in the first year after PCN. They concluded that PCN is a poor replacement for conventional open surgery [35]. However, in their retrospective cohort study, Rooij et al. reported that the reoperation rate of 158 patients over 41.5 months was 21.4%. They concluded that the reoperation rate was acceptable and suggested a potential role for PCN as a less invasive treatment option before ACD [36]. Our data show that 90 PCN patients were recruited in our series, and only one patient received ADR three months after PCN due to a lack of improvement. Another three patients received a second PCN after 11, 14, and 43 months. Our re-surgery rate was approximately 4.44% (4/90) within an average of 30.44 ± 24.36 months after surgery. This drastic difference in results between studies may be due to patient selection [34, 37]. The decision making for performing PCN should be based on several parameters which including the patients’ age, symptoms, signs and the image characteristics. Despite the disc degeneration that can progress with age, the most optimal stepwise therapeutic policies should be adopted in accordance to this reason. PCN is a simple, safe, time-saving, outpatient clinical surgery that possesses good value for symptomatic contained CHIVD, especially after short-term failure to respond to CT, too early to receive open surgery, or general anesthesia are contraindicated due to complicated medical problems [13, 14]. We believe that PCN does not represent an alternative to PCD, ACD and ADR [24], but may be used to postpone or to decrease the need for eventual-step cervical fusion surgery to treat degenerative cervical disc disease [16]. However, it may have a potential role as a less invasive treatment option, before ACD is considered, for cervical radicular pain due to soft disc herniation [36].

In addition to PCN’s role in alleviating cervical discogenic pain, some authors have documented its effectiveness as a treatment for cervicogenic vertigo [38, 39]. The concept of cervicogenic vertigo was first proposed by Ryan et al. in 1955 [40]. It is believed to be related to Ruffini corpuscles in degenerative cervical discs [41]. However, as definite diagnostic criteria and strong clinical evidence are lacking, the effects of PCN on cervicogenic vertigo need to be validated.

Although this study conducted follow-up X-rays of the cervical spine, some patients did not come to the clinic for these final imaging analyses, resulting in loss to follow-up, which might have led to some inconsistencies in the total number of cases included in the analysis. The present study also has a number of other limitations, such as the small number of cases, lack of randomization, and use of only two-dimensional follow-up images. In addition, six months of follow-up may be insufficient. A longer follow-up period may provide additional information on the recovery of the CT group and recurrent pain after surgery. However, we believe that these preliminary data can provide a new and useful clinical understanding of the effectiveness of PCN.

Conclusion

For contained CHIVD patients with symptoms after a period of invalid CT, prompt treatment with PCN instead of persistent CT is recommended. The progression of disc degeneration due to the loss of disc height is not a critical issue for the mid-term outcomes of PCN, which was associated with a low rate of re-surgery.

Supporting information

S1 Appendix. Institutional Review Board certificate of the study protocol.

(PDF)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

CDC was supported by China Medical University Hospital [DMR-111-097] for providing technical and financial support https://www.cmuh.cmu.edu.tw/Home/CmuhIndex_EN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Van Zundert J, Huntoon M, Patijn J, Lataster A, Mekhail N, et al. (2010) 4. Cervical radicular pain. Pain Pract 10: 1–17. doi: 10.1111/j.1533-2500.2009.00319.x [DOI] [PubMed] [Google Scholar]
  • 2.Cloward RB. (1959) Cervical diskography. A contribution to the etiology and mechanism of neck, shoulder and arm pain. Ann Surg 150: 1052–1064. doi: 10.1097/00000658-195912000-00013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gebremariam L, Koes BW, Peul WC, Huisstede BM. (2012) Evaluation of treatment effectiveness for the herniated cervical disc: a systematic review. Spine (Phila Pa 1976) 37: E109–118. doi: 10.1097/BRS.0b013e318221b5af [DOI] [PubMed] [Google Scholar]
  • 4.Sugawara T. (2015) Anterior Cervical Spine Surgery for Degenerative Disease: A Review. Neurol Med Chir (Tokyo) 55: 540–546. doi: 10.2176/nmc.ra.2014-0403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bao QB, Yuan HA. (2000) Artificial disc technology. Neurosurg Focus 9: e14. doi: 10.3171/foc.2000.9.4.14 [DOI] [PubMed] [Google Scholar]
  • 6.Gerges FJ, Lipsitz SR, Nedeljkovic SS. (2010) A systematic review on the effectiveness of the Nucleoplasty procedure for discogenic pain. Pain Physician 13: 117–132. [PubMed] [Google Scholar]
  • 7.Wullems JA, Halim W, van der Weegen W. (2014) Current evidence of percutaneous nucleoplasty for the cervical herniated disk: a systematic review. Pain Pract 14: 559–569. doi: 10.1111/papr.12122 [DOI] [PubMed] [Google Scholar]
  • 8.Chen YC, Lee SH, Chen D. (2003) Intradiscal pressure study of percutaneous disc decompression with nucleoplasty in human cadavers. Spine (Phila Pa 1976) 28: 661–665. doi: 10.1097/01.BRS.0000051920.45671.88 [DOI] [PubMed] [Google Scholar]
  • 9.Ren D, Zhang Z, Sun T, Li F. (2015) Effect of percutaneous nucleoplasty with coblation on phospholipase A2 activity in the intervertebral disks of an animal model of intervertebral disk degeneration: a randomized controlled trial. J Orthop Surg Res 10: 38. doi: 10.1186/s13018-015-0175-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.O’Neill CW, Liu JJ, Leibenberg E, Hu SS, Deviren V, et al. (2004) Percutaneous plasma decompression alters cytokine expression in injured porcine intervertebral discs. Spine J 4: 88–98. doi: 10.1016/s1529-9430(03)00423-6 [DOI] [PubMed] [Google Scholar]
  • 11.Birnbaum K. (2009) Percutaneous cervical disc decompression. Surg Radiol Anat 31: 379–387. doi: 10.1007/s00276-009-0462-6 [DOI] [PubMed] [Google Scholar]
  • 12.Sharps LS, Isaac Z. (2002) Percutaneous disc decompression using nucleoplasty. Pain Physician 5: 121–126. [PubMed] [Google Scholar]
  • 13.Yan D, Li J, Zhu H, Zhang Z, Duan L. (2010) Percutaneous cervical nucleoplasty and percutaneous cervical discectomy treatments of the contained cervical disc herniation. Arch Orthop Trauma Surg 130: 1371–1376. doi: 10.1007/s00402-009-1041-3 [DOI] [PubMed] [Google Scholar]
  • 14.Karaman H, Tufek A, Olmez Kavak G, Yildirim ZB, Temel V, et al. (2011) Effectiveness of nucleoplasty applied for chronic radicular pain. Med Sci Monit 17: CR461–466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ierardi AM, Carnevale A, Cossu A, Coppola A, Fumarola EM, et al. (2020) Percutaneous cervical discectomy: retrospective comparison of two different techniques. Radiol Med 125: 569–577. doi: 10.1007/s11547-020-01133-x [DOI] [PubMed] [Google Scholar]
  • 16.Yang B, Xie J, Yin B, Wang L, Fang S, et al. (2014) Treatment of cervical disc herniation through percutaneous minimally invasive techniques. Eur Spine J 23: 382–388. doi: 10.1007/s00586-013-3063-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Eichen PM, Achilles N, Konig V, Mosges R, Hellmich M, et al. (2014) Nucleoplasty, a minimally invasive procedure for disc decompression: a systematic review and meta-analysis of published clinical studies. Pain Physician 17: E149–173. [PubMed] [Google Scholar]
  • 18.Cuellar VG, Cuellar JM, Vaccaro AR, Carragee EJ, Scuderi GJ. (2010) Accelerated degeneration after failed cervical and lumbar nucleoplasty. J Spinal Disord Tech 23: 521–524. doi: 10.1097/BSD.0b013e3181cc90dd [DOI] [PubMed] [Google Scholar]
  • 19.McCarthy M Jr., Chang CH, Pickard AS, Giobbie-Hurder A, Price DD, et al. (2005) Visual analog scales for assessing surgical pain. J Am Coll Surg 201: 245–252. doi: 10.1016/j.jamcollsurg.2005.03.034 [DOI] [PubMed] [Google Scholar]
  • 20.Fairbank JC, Pynsent PB. (2000) The Oswestry Disability Index. Spine (Phila Pa 1976) 25: 2940–2952; discussion 2952. doi: 10.1097/00007632-200011150-00017 [DOI] [PubMed] [Google Scholar]
  • 21.McCormick JD, Werner BC, Shimer AL. (2013) Patient-reported outcome measures in spine surgery. J Am Acad Orthop Surg 21: 99–107. doi: 10.5435/JAAOS-21-02-99 [DOI] [PubMed] [Google Scholar]
  • 22.Scheer JK, Tang JA, Smith JS, Acosta FL Jr., Protopsaltis TS, et al. (2013) Cervical spine alignment, sagittal deformity, and clinical implications: a review. J Neurosurg Spine 19: 141–159. doi: 10.3171/2013.4.SPINE12838 [DOI] [PubMed] [Google Scholar]
  • 23.Cesaroni A, Nardi PV. (2010) Plasma disc decompression for contained cervical disc herniation: a randomized, controlled trial. Eur Spine J 19: 477–486. doi: 10.1007/s00586-009-1189-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.de Rooij J, Harhangi B, Aukes H, Groeneweg G, Stronks D, et al. (2020) The Effect of Percutaneous Nucleoplasty vs Anterior Discectomy in Patients with Cervical Radicular Pain due to a Single-Level Contained Soft-Disc Herniation: A Randomized Controlled Trial. Pain Physician 23: 553–564. [PubMed] [Google Scholar]
  • 25.Epstein NE. (2017) Percutaneous cervical laser diskectomy, thermoannuloplasty, and thermonucleoplasty; comparable results without surgery. Surg Neurol Int 8: 128. doi: 10.4103/sni.sni_164_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kobayashi N, Asamoto S, Doi H, Ikeda Y, Matusmoto K. (2003) Spontaneous regression of herniated cervical disc. Spine J 3: 171–173. doi: 10.1016/s1529-9430(02)00556-9 [DOI] [PubMed] [Google Scholar]
  • 27.Mochida K, Komori H, Okawa A, Muneta T, Haro H, et al. (1998) Regression of cervical disc herniation observed on magnetic resonance images. Spine (Phila Pa 1976) 23: 990–995; discussion 996–997. doi: 10.1097/00007632-199805010-00005 [DOI] [PubMed] [Google Scholar]
  • 28.Kim JY, Kim IS, Hong JT, Sung JH, Lee SW. (2015) Inferior thyroid arterial injury after percutaneous cervical nucleoplasty. Spine J 15: 1495–1496. doi: 10.1016/j.spinee.2015.03.024 [DOI] [PubMed] [Google Scholar]
  • 29.Lee SJ, Choi EJ, Nahm FS. (2013) Spondylodiscitis after Cervical Nucleoplasty without Any Abnormal Laboratory Findings. Korean J Pain 26: 181–185. doi: 10.3344/kjp.2013.26.2.181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kong L, Tian W, Cao P, Wang H, Zhang B, et al. (2017) Predictive factors associated with neck pain in patients with cervical disc degeneration: A cross-sectional study focusing on Modic changes. Medicine (Baltimore) 96: e8447. doi: 10.1097/MD.0000000000008447 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chang H, Baek DH, Choi BW. (2014) The Relationship between Increased Intervertebral Disc Height and Development of Postoperative Axial Neck Pain after Anterior Cervical Fusion. J Korean Neurosurg Soc 55: 343–347. doi: 10.3340/jkns.2014.55.6.343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Li H, Lou J, Liu H, Wang B. (2016) Effect of intervertebral disc height on the range of motion and clinical outcomes after single-level implantation of Prestige LP cervical disc prosthesis. Clin Neurol Neurosurg 148: 1–4. doi: 10.1016/j.clineuro.2016.06.010 [DOI] [PubMed] [Google Scholar]
  • 33.Bhagia SM, Slipman CW, Nirschl M, Isaac Z, El-Abd O, et al. (2006) Side effects and complications after percutaneous disc decompression using coblation technology. Am J Phys Med Rehabil 85: 6–13. doi: 10.1097/01.phm.0000184153.98344.a4 [DOI] [PubMed] [Google Scholar]
  • 34.de Rooij JD, Gadjradj PS, Soria van Hoeve JS, Huygen FJ, Aukes HA, et al. (2017) Percutaneous Nucleoplasty for the Treatment of a Contained Cervical Disk Herniation. Clin Spine Surg 30: 389–391. doi: 10.1097/BSD.0000000000000583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Klessinger S. (2018) The Frequency of Re-Surgery After Cervical Disc Nucleoplasty. World Neurosurg 117: e552–e556. doi: 10.1016/j.wneu.2018.06.075 [DOI] [PubMed] [Google Scholar]
  • 36.de Rooij JD, Gadjradj PS, Aukes H, Groeneweg G, Speksnijder CM, et al. (2022) Long-Term Clinical Results of Percutaneous Cervical Nucleoplasty for Cervical Radicular Pain: A Retrospective Cohort Study. J Pain Res 15: 1433–1441. doi: 10.2147/JPR.S359512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Halim W, Wullems JA, Lim T, Aukes HA, van der Weegen W, et al. (2013) The long-term efficacy and safety of percutaneous cervical nucleoplasty in patients with a contained herniated disk. Pain Pract 13: 364–371. doi: 10.1111/papr.12003 [DOI] [PubMed] [Google Scholar]
  • 38.Li C, Qi Y, Liu G, Yin X, Jin Y, et al. (2020) Long-Term Clinical Outcomes of Percutaneous Cervical Nucleoplasty for Cervical Degenerative Diseases with Neck Pain and Cervical Vertigo. World Neurosurg 133: e205–e210. doi: 10.1016/j.wneu.2019.08.210 [DOI] [PubMed] [Google Scholar]
  • 39.Li S, Chen R, Chen Y, Mo G, Zhang L, et al. (2019) Therapeutic Effects and Safety of Percutaneous Disc Decompression with Coblation Nucleoplasty in Cervical Vertigo: A Retrospective Outcome Study with 74 Consecutive Patients and Minimum 1-Year Follow-Up. Pain Physician 22: E205–E214. [PubMed] [Google Scholar]
  • 40.Ryan GM, Cope S. (1955) Cervical vertigo. Lancet 269: 1355–1358. doi: 10.1016/s0140-6736(55)93159-7 [DOI] [PubMed] [Google Scholar]
  • 41.Li Y, Peng B. (2015) Pathogenesis, Diagnosis, and Treatment of Cervical Vertigo. Pain Physician 18: E583–595. [PubMed] [Google Scholar]

Decision Letter 0

Andrea Giannini

10 Oct 2022

PONE-D-22-22166Analysis of the Clinical and Radiological Outcomes of Percutaneous Cervical Nucleoplasty: A Case–Control StudyPLOS ONE

Dear Dr. Chiu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Andrea Giannini

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. During the internal evaluation of the documents provided. It is in our understanding that the participants were enrolled into each surgical group independent of research, at the physician's discretion. As such we would be grateful if you could report this within the mansucript text to avoid confusion with a possible clinical trial. Please also remove the TREND check list and IRB approved study protocols from the supporting material as this is not required for your article type.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

   "Dr. Cheng-Di Chiu was supported by China Medical University Hospital [DMR-111-097] for providing technical and financial support."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

   "CDC was supported by China Medical University Hospital [DMR-111-097] for providing technical and financial support https://www.cmuh.cmu.edu.tw/Home/CmuhIndex_EN.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

Dear authors,

the topic of the present article titled “Analysis of the Clinical and Radiological Outcomes of Percutaneous Cervical Nucleoplasty: A Case–Control Study” is very interesting, the paper and the aim falls within the scope of the journal but the article needs major improvements.

Review some spellings. Methods and discussion should be modified and improved.

I suggest improving the manuscript with the reviewers' comments.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is my review about "Analysis of the Clinical and Radiological Outcomes of Percutaneous Cervical Nucleoplasty: A Case–Control Study".

The study deals with the outcomes of symptomatic 34

contained CHIVD treated with PCN or CT.

The present study was designed as a case–control comparative study. Patients who

indicated for PCN after a failed CT for more than 6 months were recruited.

Could you please comment to these more recent papers and compare with your results:

2022 May 17;15:1433-1441. doi: 10.2147/JPR.S359512. eCollection 2022.

Long-Term Clinical Results of Percutaneous Cervical Nucleoplasty for Cervical Radicular Pain: A Retrospective Cohort Study

Judith Divera de Rooij

2020 Nov;23(6):553-564.

The Effect of Percutaneous Nucleoplasty vs Anterior Discectomy in Patients with Cervical Radicular Pain due to a Single-Level Contained Soft-Disc Herniation: A Randomized Controlled Trial

Judith de Rooij

2020 Jan;133:e205-e210. doi: 10.1016/j.wneu.2019.08.210. Epub 2019 Sep 5.

Long-Term Clinical Outcomes of Percutaneous Cervical Nucleoplasty for Cervical Degenerative Diseases with Neck Pain and Cervical Vertigo

Chungen Li

2019 May;22(3):E205-E214.

Therapeutic Effects and Safety of Percutaneous Disc Decompression with Coblation Nucleoplasty in Cervical Vertigo: A Retrospective Outcome Study with 74 Consecutive Patients and Minimum 1-Year Follow-Up

Shangfu Li

Reviewer #2: The manuscript technically sound,the data support the data and conclusion ,the statistical analysis been performed appropriately and rigorously

The manuscript presented in an intelligible fashion and written in standard English

Reviewer #3: The manuscript was good written and can be accepted.

English language is good.

The results were good arranged after well described materials and methods.

The results were supported by figures

Discussion was good including conclusions

Reviewer #4: First of all, I apologize you to say rude things.

This manuscript seems a kind of supplementary examination. Many previous manuscripts announced the effectiveness of PCN, nevertheless you tried to support it. Even the conclusion in this manuscript does not sound new and impressive.

#1. In line 78-79, you mentioned the chemical effectiveness of PCN using the literature written by Ren D et al. They had referred to the correlation between PCN and PLA2, not IL-1, IL-6 and TNF-alpha specifically. More precise information should be written in this manuscript.

#2. Compare to other literatures concerning about PCN, the follow-up period (six months) seems to be shorter in this study. Although the VAS score or other indicators drastically and rapidly decreased in PCN group, gradual but continuous decrease was shown even in CT group. Longer follow-up may lead the different conclusion.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 12;17(12):e0278883. doi: 10.1371/journal.pone.0278883.r002

Author response to Decision Letter 0


2 Nov 2022

Andrea Giannini, PhD

Academic Editor

PLOS ONE

Dr. Giannini:

We appreciate the opportunity to revise our manuscript entitled, “Analysis of the Clinical and Radiological Outcomes of Percutaneous Cervical Nucleoplasty: A Case–Control Study.” The manuscript ID is PONE-D-22-22166, authored by Chien-Hua Chen et al. Our responses to the comments from the editors and reviewers are included below.

We acknowledge the reviewers’ constructive comments and have addressed each comment in our point-by-point response. We have incorporated various corrections into the revised manuscript, according to the suggestions made by the reviewers and editors. A detailed list of our replies to the reviewers’ comments and the changes made in response to these comments is provided on the following pages of the “Authors’ Response to Editors and Reviewers.” Please feel free to contact us with any questions.

Your kind consideration of our manuscript is highly appreciated.

Sincerely yours,

Authors’ Response to Editors and Reviewers

Academic editor’s points

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Answer: The manuscript has been amended to meet PLOS ONE's style requirements.

2. During the internal evaluation of the documents provided. It is in our understanding that the participants were enrolled into each surgical group independent of research, at the physician's discretion. As such we would be grateful if you could report this within the mansucript text to avoid confusion with a possible clinical trial. Please also remove the TREND check list and IRB approved study protocols from the supporting material as this is not required for your article type.

Answer: Thank you. We have reported it in the manuscript text to avoid confusion (Lines 104–105). The unnecessary documents have been removed from the supporting materials.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "Dr. Cheng-Di Chiu was supported by China Medical University Hospital [DMR-111-097] for providing technical and financial support." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "CDC was supported by China Medical University Hospital [DMR-111-097] for providing technical and financial support https://www.cmuh.cmu.edu.tw/Home/CmuhIndex_EN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Answer: Thank you for this reminder. The current Funding Statement in the online submission is correct so there is no need to update it. We have removed any funding-related text from the manuscript.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Answer: Thank you. The ethics statement is now only in the Methods section in the revised version of the manuscript.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Answer: Thank you. We have added a caption and an in-text citation for the supporting information (Lines 92 and 408).

6. Additional Editor Comments: Dear authors, the topic of the present article titled “Analysis of the Clinical and Radiological Outcomes of Percutaneous Cervical Nucleoplasty: A Case–Control Study” is very interesting, the paper and the aim falls within the scope of the journal but the article needs major improvements. Review some spellings. Methods and discussion should be modified and improved. I suggest improving the manuscript with the reviewers' comments.

Answer: Thank you. We have further improved the manuscript based on your suggestions and the reviewers’ comments.

Reviewers’ points

Reviewer #1

1. The study deals with the outcomes of symptomatic contained CHIVD treated with PCN or CT. The present study was designed as a case–control comparative study. Patients who indicated for PCN after a failed CT for more than 6 months were recruited. Could you please comment to these more recent papers and compare with your results? 2022 May 17;15:1433-1441. doi: 10.2147/JPR.S359512. eCollection 2022. Long-Term Clinical Results of Percutaneous Cervical Nucleoplasty for Cervical Radicular Pain: A Retrospective Cohort Study Judith Divera de Rooij 2020 Nov;23(6):553-564. The Effect of Percutaneous Nucleoplasty vs Anterior Discectomy in Patients with Cervical Radicular Pain due to a Single-Level Contained Soft-Disc Herniation: A Randomized Controlled Trial Judith de Rooij 2020 Jan;133:e205-e210. doi: 10.1016/j.wneu.2019.08.210. Epub 2019 Sep 5. Long-Term Clinical Outcomes of Percutaneous Cervical Nucleoplasty for Cervical Degenerative Diseases with Neck Pain and Cervical Vertigo Chungen Li 2019 May;22(3):E205-E214. Therapeutic Effects and Safety of Percutaneous Disc Decompression with Coblation Nucleoplasty in Cervical Vertigo: A Retrospective Outcome Study with 74 Consecutive Patients and Minimum 1-Year Follow-Up Shangfu Li

Answer: Thank you for the comments and suggestion. We have updated the manuscript, commented on these more recent papers, and compared their results with ours (Lines 231–233, 265–270, 283–291).

Reviewer #2

1. The manuscript technically sound,the data support the data and conclusion ,the statistical analysis been performed appropriately and rigorously The manuscript presented in an intelligible fashion and written in standard English.

Answer: Thank you for your evaluation and comments.

Reviewer #3

1. The manuscript was good written and can be accepted. English language is good. The results were good arranged after well described materials and methods. The results were supported by figures. Discussion was good including conclusions.

Answer: Thank you for your evaluation and comments.

Reviewer #4

1. First of all, I apologize you to say rude things. This manuscript seems a kind of supplementary examination. Many previous manuscripts announced the effectiveness of PCN, nevertheless you tried to support it. Even the conclusion in this manuscript does not sound new and impressive. In line 78-79, you mentioned the chemical effectiveness of PCN using the literature written by Ren D et al. They had referred to the correlation between PCN and PLA2, not IL-1, IL-6 and TNF-alpha specifically. More precise information should be written in this manuscript.

Answer: Thank you for your comments. We have incorporated more precise information in the introduction, which addresses the impact of PCN on IL-1and IL-8 expression in disc tissue (Lines 68–73). In addition to its degradation of PLA2 activity, another study provided evidence that nucleoplasty decreased IL-1 expression and promoted IL-8 expression, implying the impacts of nucleoplasty on disc regeneration.

2. Compare to other literatures concerning about PCN, the follow-up period (six months) seems to be shorter in this study. Although the VAS score or other indicators drastically and rapidly decreased in PCN group, gradual but continuous decrease was shown even in CT group. Longer follow-up may lead the different conclusion.

Answer: Thank you for your comments. We agree with the reviewer’s perspective on the follow-up period. A longer follow-up period may provide additional information on the recovery of the CT group and recurrent pain after surgery. We discuss the insufficient length of the follow-up period in the section on limitations (Lines 296–298). To our knowledge, two studies with control participants had a longer follow-up period compared to the present study (ref. 11 & 23). However, our study recruited patients who had received CT for 6 months prior to enrollment. This means that the control participants in our study had already received 12 months of CT by the 6th month of the study period, at the time when PCN still showed a higher effect on pain relief than CT. We emphasize that timely PCN treatment may be a better choice for reducing pain compared to continued and lengthy CT.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Andrea Giannini

28 Nov 2022

Analysis of the Clinical and Radiological Outcomes of Percutaneous Cervical Nucleoplasty: A Case–Control Study

PONE-D-22-22166R1

Dear Dr. Cheng-Di Chiu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Andrea Giannini

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The manuscript has been modified with the comments of the reviewers. It is now ready to be published.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: interested research with appropriate language and correct statistically. The results was excited.

the research technically sound piece of scientific research with the data support the conclusions. Experiments have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions have be drawn appropriately based on the data presented.

Reviewer #3: The manuscript is interesting and good written and discussed.

Introduction: was good and include aim of the work.

Materials and methods: were good designed.

Results: were good described.

Discussion: was good written.

Reviewer #4: Thank you for correcting your manuscript.

In the present study, the superiority of PCN after long-term follow-up is uncertain compared with CT, however, the the potential of rapid recovery is almost obvious. Hence, this manuscript must be a boon for the patient suffering from CHIVD.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Jens-Christian Altenbernd

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

Acceptance letter

Andrea Giannini

1 Dec 2022

PONE-D-22-22166R1

Analysis of the clinical and radiological outcomes of percutaneous cervical nucleoplasty: A case–control study

Dear Dr. Chiu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Andrea Giannini

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Institutional Review Board certificate of the study protocol.

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES